title: 8pter-p23 deletion is associated with racial differences in prostate cancer outcome.
abstract: Deletions of chromosome sequences mapping to the short arm of chromosome 8 have been observed frequently in a variety of human cancers. A small number of studies have suggested that the terminal portion of the short arm of chromosome 8, 8pter-p23, may be deleted independently of other portions of 8p in human tumors, and that deletion of the 8pter-p23 region may be correlated with poor prognosis. The aim of the present study was to physically define the minimal region of 8pter-p23 deletion and to define the frequency and prognostic significance of 8pter-p23 loss in human prostate tumors. DNA was purified from normal and tumor tissues of 45 radical prostatectomy specimens and amplified for 15 highly polymorphic microsatellite sequences, 13 spanning 8pter-p23 and 2 proximal 8p markers. Allelic loss of 8p sequences was observed in 28 of 45 (62%) tumors examined. Of these, approximately half (12 of 28; 43%) demonstrated independent loss of the 8pter-p23 region, with several tumors defining a 5-cM minimal region of deletion spanning D8S264-D8S1824-D8S1781-D8S262-D8S1798. When serum prostate-specific antigen was used as a surrogate end point marker for survival, 8pter-p23 loss was significantly associated with reduced disease-free progression (log-rank P = 0.0426). Moreover, loss of the 8pter-p23 region was significantly associated with poor survival for American Caucasian (log-rank P = 0.0024) but not African-American (log-rank P = 0.5832) prostate cancer patients. These studies suggest that independent deletion of 8pter-p23 is differentially associated with disease recurrence and poor outcome in American Caucasian but not African-American prostate cancer patients.
authors.affiliation: Department of Surgery, The University of Michigan, Ann Arbor 48109-0946, USA.
authors.forename: J G
authors.initials: JG
authors.lastname: Washburn
authors.forename: K J
authors.initials: KJ
authors.lastname: Wojno
authors.forename: J
authors.initials: J
authors.lastname: Dey
authors.forename: I J
authors.initials: IJ
authors.lastname: Powell
authors.forename: J A
authors.initials: JA
authors.lastname: Macoska
mesh_terms: D000368:Aged; D000483:Alleles; D044383:Black People; D002872:Chromosome Deletion; D002898:Chromosomes, Human, Pair 8; D018572:Disease-Free Survival; D006801:Humans; D019656:Loss of Heterozygosity; D008297:Male; D018895:Microsatellite Repeats; D008875:Middle Aged; D011379:Prognosis; D016016:Proportional Hazards Models; D017430:Prostate-Specific Antigen / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000208:ethnology* / Q000235:genetics* / Q000401:mortality*; D012307:Risk Factors; D013997:Time Factors; D016896:Treatment Outcome; D044465:White People; D001741:Black or African American
chemical_list: D017430:Prostate-Specific Antigen